A Phase 2, randomized, double-blind, placebo-controlled, parallel group, proof-of concept study assessing the efficacy and safety of amlitelimab in adult participants with moderate to severe hidradenitis suppurativa

Project: Research

Project Details

StatusActive
Effective start/end date10/01/24 → 10/01/27

Keywords

  • clinical trial
  • hidradenitis suppurativa
  • Dermatology